Literature DB >> 27240956

Epigenetic dysregulation of interleukin 8 (CXCL8) hypersecretion in cystic fibrosis airway epithelial cells.

Anna Poghosyan1, Jamie K Patel2, Rachel L Clifford2, Alan J Knox3.   

Abstract

Airway epithelial cells in cystic fibrosis (CF) overexpress Interleukin 8 (CXCL8) through poorly defined mechanisms. CXCL8 transcription is dependent on coordinated binding of CCAAT/enhancer binding protein (C/EBP)β, nuclear factor (NF)-κB, and activator protein (AP)-1 to the promoter. Here we show abnormal epigenetic regulation is responsible for CXCL8 overexpression in CF cells. Under basal conditions CF cells had increased bromodomain (Brd)3 and Brd4 recruitment and enhanced NF-κB and C/EBPβ binding to the CXCL8 promoter compared to non-CF cells due to trimethylation of histone H3 at lysine 4 (H3K4me3) and DNA hypomethylation at CpG6. IL-1β increased NF-κB, C/EBPβ and Brd4 binding. Furthermore, inhibitors of bromodomain and extra-terminal domain family (BET) proteins reduced CXCL8 production in CF cells suggesting a therapeutic target for the BET pathway.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BRD4; CF; CXCL8; Epigenetics

Mesh:

Substances:

Year:  2016        PMID: 27240956     DOI: 10.1016/j.bbrc.2016.05.140

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Role of vitamin D in cystic fibrosis and non-cystic fibrosis bronchiectasis.

Authors:  Maria Moustaki; Ioanna Loukou; Kostas N Priftis; Konstantinos Douros
Journal:  World J Clin Pediatr       Date:  2017-08-08

2.  Wnt1 silences chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma.

Authors:  Dimitra Kerdidani; Panagiotis Chouvardas; Ares Rocanin Arjo; Ioanna Giopanou; Giannoula Ntaliarda; Yu Amanda Guo; Mary Tsikitis; Georgios Kazamias; Konstantinos Potaris; Georgios T Stathopoulos; Spyros Zakynthinos; Ioannis Kalomenidis; Vassili Soumelis; George Kollias; Maria Tsoumakidou
Journal:  Nat Commun       Date:  2019-03-29       Impact factor: 14.919

3.  Recombinant Acid Ceramidase Reduces Inflammation and Infection in Cystic Fibrosis.

Authors:  Aaron I Gardner; Iram J Haq; A John Simpson; Katrin A Becker; John Gallagher; Vinciane Saint-Criq; Bernard Verdon; Emily Mavin; Alexandra Trigg; Michael A Gray; Albert Koulman; Melissa J McDonnell; Andrew J Fisher; Elizabeth L Kramer; John P Clancy; Christopher Ward; Edward H Schuchman; Erich Gulbins; Malcolm Brodlie
Journal:  Am J Respir Crit Care Med       Date:  2020-10-15       Impact factor: 21.405

4.  Pharmacologic Targeting of BET Proteins Attenuates Hyperuricemic Nephropathy in Rats.

Authors:  Chongxiang Xiong; Jin Deng; Xin Wang; Xiaofei Shao; Qin Zhou; Hequn Zou; Shougang Zhuang
Journal:  Front Pharmacol       Date:  2021-02-16       Impact factor: 5.810

Review 5.  Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology.

Authors:  Simona Barone; Emilia Cassese; Antonella Ilenia Alfano; Margherita Brindisi; Vincenzo Summa
Journal:  J Med Chem       Date:  2022-02-11       Impact factor: 7.446

Review 6.  Role of Cystic Fibrosis Bronchial Epithelium in Neutrophil Chemotaxis.

Authors:  Giulio Cabrini; Alessandro Rimessi; Monica Borgatti; Ilaria Lampronti; Alessia Finotti; Paolo Pinton; Roberto Gambari
Journal:  Front Immunol       Date:  2020-08-04       Impact factor: 7.561

Review 7.  MCPIP1 RNase and Its Multifaceted Role.

Authors:  Richard Musson; Weronika Szukała; Jolanta Jura
Journal:  Int J Mol Sci       Date:  2020-09-29       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.